Hangzhou Alltest Biotech Co., Ltd. engages in the research, development, production, and sale of in vitro diagnostic reagents in China and internationally. The company offers rapid diagnostic reagents, including drug and drug abuse, infectious disease, women's health, tumor marker, and cardiac marker testing products. Its products include COVID-19 antigen and antibody tests; veterinary tests; fluorescence immunoassay tests and analyzers; urine analysis solutions, biochemistry reagents, VTM, blood glucose monitoring systems, and HB hemoglobin test meters. In addition, the company offers SARS-COV-2 RT-qPCR assays, virus specimen stabilizers, and viral DNA/RNA extraction kits; and other test products. Its products are used in clinical testing, on-site testing, personal health management, and other fields. Hangzhou Alltest Biotech Co., Ltd. was founded in 2009 and is based in Hangzhou, China.
Stock data | 2024 | Change |
---|---|---|
Price | $8.00 | N/A |
Market Cap | $634.10M | N/A |
Shares Outstanding | 79.28M | N/A |
Employees | 1.24K | N/A |